These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 19897107)

  • 1. Pancreatic network control of glucagon secretion and counterregulation.
    Farhy LS; McCall AL
    Methods Enzymol; 2009; 467():547-581. PubMed ID: 19897107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Models of glucagon secretion, their application to the analysis of the defects in glucagon counterregulation and potential extension to approximate glucagon action.
    Farhy LS; McCall AL
    J Diabetes Sci Technol; 2010 Nov; 4(6):1345-56. PubMed ID: 21129329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. System-level control to optimize glucagon counterregulation by switch-off of α-cell suppressing signals in β-cell deficiency.
    Farhy LS; McCall AL
    J Diabetes Sci Technol; 2009 Jan; 3(1):21-33. PubMed ID: 20046648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amplification of pulsatile glucagon counterregulation by switch-off of alpha-cell-suppressing signals in streptozotocin-treated rats.
    Farhy LS; Du Z; Zeng Q; Veldhuis PP; Johnson ML; Brayman KL; McCall AL
    Am J Physiol Endocrinol Metab; 2008 Sep; 295(3):E575-85. PubMed ID: 18577688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimizing reduction in basal hyperglucagonaemia to repair defective glucagon counterregulation in insulin deficiency.
    Farhy LS; McCall AL
    Diabetes Obes Metab; 2011 Oct; 13 Suppl 1(0 1):133-43. PubMed ID: 21824267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Basal hyperglucagonemia with impaired glucagon counterregulation in type 1 diabetes.
    Farhy LS; Chan A; Breton MD; Anderson SM; Kovatchev BP; McCall AL
    Front Physiol; 2012; 3():40. PubMed ID: 22403550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pax4 transdifferentiates glucagon-secreting alpha cells to insulin-secreting beta endocrine pancreatic cells].
    Collombat P; Mansouri A
    Med Sci (Paris); 2009; 25(8-9):763-5. PubMed ID: 19765395
    [No Abstract]   [Full Text] [Related]  

  • 8. Regulation of alpha-cell function by the beta-cell in isolated human and rat islets deprived of glucose: the "switch-off" hypothesis.
    Hope KM; Tran PO; Zhou H; Oseid E; Leroy E; Robertson RP
    Diabetes; 2004 Jun; 53(6):1488-95. PubMed ID: 15161753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurotransmitter control of islet hormone pulsatility.
    Gylfe E; Tengholm A
    Diabetes Obes Metab; 2014 Sep; 16 Suppl 1():102-10. PubMed ID: 25200303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of glucagon secretion.
    Young A
    Adv Pharmacol; 2005; 52():151-71. PubMed ID: 16492545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose control of glucagon secretion-'There's a brand-new gimmick every year'.
    Gylfe E
    Ups J Med Sci; 2016 May; 121(2):120-32. PubMed ID: 27044660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CART is overexpressed in human type 2 diabetic islets and inhibits glucagon secretion and increases insulin secretion.
    Abels M; Riva M; Bennet H; Ahlqvist E; Dyachok O; Nagaraj V; Shcherbina L; Fred RG; Poon W; Sörhede-Winzell M; Fadista J; Lindqvist A; Kask L; Sathanoori R; Dekker-Nitert M; Kuhar MJ; Ahrén B; Wollheim CB; Hansson O; Tengholm A; Fex M; Renström E; Groop L; Lyssenko V; Wierup N
    Diabetologia; 2016 Sep; 59(9):1928-37. PubMed ID: 27338624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paracrine regulation of glucagon secretion: the β/α/δ model.
    Watts M; Ha J; Kimchi O; Sherman A
    Am J Physiol Endocrinol Metab; 2016 Apr; 310(8):E597-E611. PubMed ID: 26837808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elimination of von Hippel-Lindau function perturbs pancreas endocrine homeostasis in mice.
    Puri S; García-Núñez A; Hebrok M; Cano DA
    PLoS One; 2013; 8(8):e72213. PubMed ID: 23977255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ATP-sensitive K+ channel mediates the zinc switch-off signal for glucagon response during glucose deprivation.
    Slucca M; Harmon JS; Oseid EA; Bryan J; Robertson RP
    Diabetes; 2010 Jan; 59(1):128-34. PubMed ID: 19808893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autophagy deficiency in β cells blunts incretin-induced suppression of glucagon release from α cells.
    Kim MJ; Choi OK; Chae KS; Lee H; Chung SS; Ham DS; Kim JW; Yoon KH; Park KS; Jung HS
    Islets; 2015; 7(5):e1129096. PubMed ID: 26744903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conflicting Views About Interactions Between Pancreatic α-Cells and β-Cells.
    Weir GC; Bonner-Weir S
    Diabetes; 2023 Dec; 72(12):1741-1747. PubMed ID: 37983524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatostatin receptor type 2 antagonism improves glucagon counterregulation in biobreeding diabetic rats.
    Karimian N; Qin T; Liang T; Osundiji M; Huang Y; Teich T; Riddell MC; Cattral MS; Coy DH; Vranic M; Gaisano HY
    Diabetes; 2013 Aug; 62(8):2968-77. PubMed ID: 23630299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Automated recognition and quantification of pancreatic islets in Zucker diabetic fatty rats treated with exendin-4.
    Kakimoto T; Kimata H; Iwasaki S; Fukunari A; Utsumi H
    J Endocrinol; 2013 Jan; 216(1):13-20. PubMed ID: 23092878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reestablishment of Glucose Inhibition of Glucagon Secretion in Small Pseudoislets.
    Reissaus CA; Piston DW
    Diabetes; 2017 Apr; 66(4):960-969. PubMed ID: 28130310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.